130 related articles for article (PubMed ID: 30753760)
1. Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.
Dobson ET; Bloch MH; Strawn JR
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30753760
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
Mills JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability.
Dobson ET; Strawn JR
Paediatr Drugs; 2016 Feb; 18(1):45-53. PubMed ID: 26660158
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
6. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults.
Mills JA; Mendez E; Strawn JR
J Child Adolesc Psychopharmacol; 2024 May; ():. PubMed ID: 38800869
[No Abstract] [Full Text] [Related]
8. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
[TBL] [Abstract][Full Text] [Related]
9. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Slee A; Nazareth I; Bondaronek P; Liu Y; Cheng Z; Freemantle N
Lancet; 2019 Feb; 393(10173):768-777. PubMed ID: 30712879
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.
Mossman SA; Mills JA; Walkup JT; Strawn JR
J Child Adolesc Psychopharmacol; 2021 May; 31(4):259-267. PubMed ID: 33887154
[No Abstract] [Full Text] [Related]
12. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
Arnardóttir A; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):118-126. PubMed ID: 35507829
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis.
He H; Xiang Y; Gao F; Bai L; Gao F; Fan Y; Lyu J; Ma X
J Psychiatr Res; 2019 Nov; 118():21-30. PubMed ID: 31473564
[TBL] [Abstract][Full Text] [Related]
14. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
Zhang W; Yan Y; Wu Y; Yang H; Zhu P; Yan F; Zhao R; Tian P; Wang T; Fan Q; Su Z
Pharmacol Res; 2022 May; 179():106204. PubMed ID: 35378276
[TBL] [Abstract][Full Text] [Related]
15. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder.
Castagna PJ; Farahdel E; Potenza MN; Crowley MJ
Expert Opin Pharmacother; 2023 May; 24(7):835-847. PubMed ID: 37074259
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis.
Chen TR; Huang HC; Hsu JH; Ouyang WC; Lin KC
J Psychiatr Res; 2019 Nov; 118():73-83. PubMed ID: 31494377
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.
Ipser JC; Carey P; Dhansay Y; Fakier N; Seedat S; Stein DJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD005473. PubMed ID: 17054260
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for post-traumatic stress disorder - a systematic review and meta-analysis.
Ipser J; Seedat S; Stein DJ
S Afr Med J; 2006 Oct; 96(10):1088-96. PubMed ID: 17164942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
